Sign in

CIK 0001645460

  • Non-accelerated filer
  • Smaller reporting company

Cue Biopharma, Inc.

Sign in to watch
Ticker
CUE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473324577
Phone
+1 617-949-2680
Business address
100 CHESTNUT STREET, SUITE 300, SOMERVILLE, MA, 02143
Former names
Imagen Biopharma, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market sale Director sold 20,176 shares at an average $17.93 ($361,690)
  9. 4 Open-market sale President and CSO sold 8,000 shares at $18.05 ($144,400)
  10. 4 Open-market sale President and CSO sold 20,000 shares at $15.07 ($301,354)
  11. 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 31,677 shares (to pay taxes)
  12. 4 Shares withheld for taxes PRESIDENT AND CSO gave up 14,134 shares (to pay taxes)
  13. 4 Open-market sale CHIEF FINANCIAL OFFICER sold 1,251 shares at $14.21 ($17,783)
  14. 4 Open-market sale PRESIDENT AND CSO sold 20,000 shares at $15.23 ($304,646)
  15. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 3,400 shares at $14.72 ($50,051)
  16. 4 Open-market sale Chief Medical Officer sold 13,439 shares at an average $15.10 ($202,894)
  17. 4 Open-market sale Chief Medical Officer sold 20,274 shares at an average $15.13 ($306,767)
  18. 4/A Open-market sale Chief Medical Officer sold 2,720 shares at $15.07 ($40,980)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 7 of 13 · 259 filings